Chronic depression is a term used in psychiatry to describe persistent, often chronic, depression that interferes with functioning and is characterized by symptoms such as the inability to gain enjoyment from life, loss of interest in daily activities, changes in sleep and/or concentration patterns and changes in appetite. Chronic depression is most common in adults aged 45 and over. It is more common in women than in men.
The term 'chronic depression' was first used in Diagnosis and Treatment of Depression, fourth edition (DSM-IV), which came out after the first description of subtypes of depression was conducted in agreement with observation and experience. A change was noted in the symptoms of patients who had been diagnosed with chronic depression. The subtypes are dysthymia, bipolar disorder, psychotic disorder, generalized anxiety disorder, post-traumatic stress disorder, and specific phobias. Of these, dysthymia is the most common. It is characterized by intense emotional distress with a four or five year period of normal functioning, followed by severe distress lasting for less than six months in a cycle that may not be repeated. Bipolar disorder, which can also affect adolescents and young adults, is characterized by major depression that results in significant disturbances in the person's functioning, with periods of mania and normal depression occurring alternately and rapidly alternating with each other.
The presence of dysthymia and major depression may indicate the presence of an underlying biological abnormality or biochemical abnormality. Similarly, the presence of dysthymia and depression may indicate the presence of a common biological abnormality, or a chemical imbalance in the brain. When a genetic abnormality or a biochemical imbalance is found, treatment is aimed at correcting the problem. In this case, the aim is to treat the underlying abnormality or biochemical imbalance. Treatment in this case is usually aimed at improving the patient's capacity to experience enjoyment, reducing symptoms, and improving quality of life.
Apart from dysthymia and major depression, there are four other major subtypes of chronic depression: bipolar disorder, dysthymia, psychotic disorder, and post-traumatic stress disorder. Each subtype has different symptoms and different levels of function. In addition, each subtype is further divided into two additional groups: neurodepressive illness, which affect those with a depressive illness; and psychotic depression, which occur after the onset of a psychotic disorder. Neurodepressive illness is typified by episodes of sadness and worthlessness that can last for longer than six months. Once the manic episode has subsided, the sufferer can go on to have dysthymic episodes.
Those with dysthymia and major depression may respond to treatments that employ both psychotherapy and medication. For patients who respond to medication, either antidepressants or selective serotonin reuptake inhibitors (SSRIs), there are two main ways to provide short-term treatment: acute therapy or chronic therapy. When an acute treatment is employed, this involves either molybdenum quinonium or verapamil, which are used to curb the emotional side effects of depression while allowing the sufferer to live normally. For patients who do not respond to acute therapy, either of these methods may be used for long periods. Acute therapy involves the use of mood stabilizers and antidepressants, which are typically used in conjunction with other forms of treatment.
One of the most important distinctions in the field of mental health is the difference between acute and chronic depression. Acute depression is usually characterized by mild symptoms, such as feelings of sadness and guilt, and it is usually caused by some injury or death of someone close to the patient. This injury or death can trigger off a "switch" within the sufferer, causing severe depression over time. If the switch occurs in the brain, as it often does, it can cause the patient to enter a state of mania or euphoria for a short period of time. The unfortunate thing is, this is not the condition that exists with chronic depression, because with chronic depression patients do not have a "switch" in their brains; they simply do not function normally when the symptoms of their disorder are triggered.
Antidepressant medications have been extremely effective for many people with chronic depression. They have been used to treat all types of this disorder, and have shown an exceptionally high success rate in controlling the symptoms and lowering the overall response rates of those suffering from this disorder. However, with medication comes a trade off: many people suffer allergic reactions to some of the more potent antidepressants, and they can lead to drug interactions with other medications. To combat this problem, Dr. Kocsis developed an anti-depressant supplement called Actonel, which contains no known allergens or toxic chemicals. With regular use, Actonel has been found to produce highly effective antidepressant response rates that surpass those of any other form of this type of medication.
Some researchers are of the opinion that the most successful way to treat chronic depression is through the use of a combination of therapy and medication. While some researchers feel that a combination of therapy and pharmacotherapy has a higher success rate than either treatment alone, it is difficult to say because there have only been a few studies on this matter. For now, the best advice that can be given to someone who is depressed is to see a mental health professional who can best recommend the right courses of action to be taken. Medication is just one of many options available to help patients suffering from chronic depression, and the right medical care is critical to achieving positive results. There are many resources available to help those suffering from chronic depression, and these include:
Comments
Post a Comment